🟢 Goodrx is trading 9.68% up in pre-market with no clearly reported company-specific catalyst

Goodrx is trading at $3.85, +9.68% in pre-market, with no clearly reported company-specific catalyst explaining the August 28, 2026 gain.

• Latest earnings, released August 5, showed $200.4 million in revenue and raised full-year guidance.
• A major shareholder’s $5.48 million stock sale was reported August 27 but does not explain the upward move.
• A catalyst may emerge later.